China Medical Technologies, Inc. (ADR) (NASDAQ:CMED)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $1.82 |
| Daily Range | $1.80 - $1.97 |
| 52-Week Range | $1.80 - $13.98 |
| Market Cap | $58.73M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | 0.53 (4.00%) |
| Volume | 0 |
| Average Daily Volume | 0 |
How do you think CMED will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CMED Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CMED News and Commentary
- Volatility Clouds 2012 Predictions – NASDAQ
- Retail, Tech and the Nasdaq's Newest Pullbacks – NASDAQ
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape – NASDAQ
- Zacks #1 Rank Additions for Friday - Tale of the Tape – NASDAQ
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape – NASDAQ
- Zacks #1 Rank Additions for Thursday - Tale of the Tape – NASDAQ
- China's Economic Miracle Going Down the Tubes: 10 Stocks to Watch – NASDAQ
- Investing 101: Short Squeeze Candidates With Insider Buying – The Motley Fool
- Investing 101: Short Squeeze Candidates with Insider Buying – NASDAQ
- China Medical Technologies Management Discusses F1Q 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Does This Mean China Medical Technologies Will Bomb Next Quarter? – The Motley Fool
- Reversal & Breakouts Trades for 7/8 – Blog at The Motley Fool
- 3 Companies for Your IPO Watchlist – The Motley Fool
- Are the Earnings at Qiagen Hiding Something? – The Motley Fool
- China Medical Technologies CEO Discusses F4Q2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Are Hologic's Earnings Better Than They Look? – The Motley Fool
- Should You Sell Hologic Right Now? – The Motley Fool
- Why Wall Street Should Love Hologic's Earnings – The Motley Fool
- Here's How Hologic May Be Failing You – The Motley Fool
- Hologic Passes This Key Test – The Motley Fool

RSS Headlines
Fool UK